Skip to main content
ESC Heart Failure logoLink to ESC Heart Failure
. 2022 Jul 9;9(5):3614–3618. doi: 10.1002/ehf2.14075

Myocardial infarction with non‐obstructive disease and anomalous coronary origin: look for the common in the uncommon

Gindomenico Disabato 1,2, Antonia Camporeale 2,, Mauro Lo Rito 3, Lara Tondi 2, Karina Geraldina Zuniga Olaya 3, Alessandro Frigiola 3, Mauro Luca Agnifili 4, Francesco Bedogni 4, Massimo Lombardi 2, Silvia Pica 2
PMCID: PMC9715779  PMID: 35809025

Abstract

Management of congenital coronary artery anomalies (CAA) is not standardized due to the variety of conditions included and their rare prevalence. Detection of CAA during myocardial infarction with non‐obstructive coronary arteries (MINOCA) may induce clinicians to address the patient for surgery as CAA is not included in any algorithm1,2 for the management of MINOCA and American Association for Thoracic Surgery evidence‐based guidelines suggest surgical repair for patients with anomalous aortic origin of a coronary artery and symptoms compatible with myocardial ischaemia.3 We present the case of a 35‐year‐old man with an anomalous origin of left coronary artery from right Valsalva sinus with pre‐pulmonic course detected during urgent coronary angiography for suspected myocardial infarction. Stress cardiac magnetic resonance did not show signs of ischaemia at high‐dose dobutamine but did reveal a recent myocarditis. This clinical case highlights the need for accurate risk stratification in CAA especially when confounding clinical scenarios co‐exist.

Keywords: MINOCA, Coronary anomaly, Cardiac magnetic resonance, Myocarditis

Introduction

The term congenital coronary artery anomalies (CAA) include a series of rare diseases characterized by abnormalities of coronary arteries in the origin, course, size or number. 1 Anomalous aortic origin of a coronary artery (AAOCA) refers to a coronary artery arising from the inappropriate sinus of Valsalva, and its prevalence varies among studies between 0.1 and 1%. 1 , 2 The wide variability may be due to referral bias, type of imaging test used, and study population. AOOCA can manifest with sudden cardiac death or symptoms of ischaemia 3 ; however, most patients are diagnosed incidentally, and consequently, the real prevalence on general population and cardiovascular risk remains unknown. 1

Left coronary artery arising from right sinus (AOOLCA) is less prevalent than the origin of right coronary artery from the inappropriate sinus (AOORCA); nevertheless, it poses the patient at higher sudden cardiac death risk at younger age (<35 years). 3

Case presentation

A 35‐year‐old Caucasian man was admitted to a secondary care centre for typical angina at rest. He had no previous medical records except for resting chest pain 5 years before with spontaneous resolution and no further medical assessment. At presentation, a 12‐lead ECG showed infero‐lateral ST elevation (Figure 1 ) without echocardiographic abnormal findings. Coronary angiography revealed anomalous aortic origin of left coronary artery from right Valsalva sinus (AAOLCA) with a long pre‐pulmonic course and without coronary obstruction. During the hospitalization, the patient remained asymptomatic, and the peak high‐sensitivity troponin I (hsTnI) was 4366.8 ng/L (99th percentile URL 19.8 ng/L) in the first day of admission. Laboratory tests detected elevated C‐reactive protein (29.5 ng/mL) with negative procalcitonin, normal blood count, and no signs of infection on urinary test and chest X‐ray.

Figure 1.

Figure 1

ECG at first admission. ECG showing ST elevation in leads V4–V5–V6 and in DII‐DIII‐aVF with specular ST down‐sloping in anterior leads (V1–V2–V3) and aVR.

The patient was referred 3 months later to our tertiary care centre to perform a surgical evaluation of the coronary anomaly, which was suspected to be responsible of acute coronary syndrome.

At admission, the patient reported no symptoms since the previous hospitalization. Coronary computed tomography angiography (CCTA) was performed to assess the anatomy of the anomalous coronary artery (Figure 2 ). Subsequently, invasive coronary angiography (Figure 3 ) and intravascular ultrasound evaluation did not reveal any pathological finding, that is, lateral systolic compression of the coronary lumen (Video S1 and Video S2).

Figure 2.

Figure 2

3D coronary computed tomography angiography reconstruction. CT reconstruction of coronary arteries. (A) Left coronary artery (labelled in yellow as AAOLCA) originates from right Valsalva sinus. (B) Pre‐pulmonic course of left coronary artery is visualized (AOOLCA and pulmonary trunk are labelled in green).

Figure 3.

Figure 3

Coronary angiography. (A) Left coronary artery (LCA) with a pre‐pulmonic course. (B) LCA and right coronary artery (RCA) arising from the same Valsalva sinus.

Stress cardiac magnetic resonance (CMR) was performed to assess induced myocardial ischaemia: Neither perfusion defect nor regional kinetic abnormality was detected at peak dobutamine infusion (i.e. 40 mcg/kg/min). However, sub‐epicardial late gadolinium enhancement involving infero‐lateral segments was detected, raising the suspicion of myocarditis (Figure 4 ). The day after, CMR was integrated by acquiring T2‐weighted images, showing signal hyperintensity compatible with residual myocardial oedema in lateral segments (Figure 4 ). According to the new diagnosis of recent myocarditis, laboratory tests were repeated, revealing mild elevation in high‐sensitivity troponin I (75 ng/L, 99th percentile URL 45 ng/L), normal CK‐MB (1 ng/mL, normal value 0.18–5 ng/mL), and negative inflammatory markers. A full panel for myocarditis, as recommended by recent European Society of Cardiology guidelines, 4 tested negative for infections or autoimmune diseases.

Figure 4.

Figure 4

CMR. (A) Sub‐epicardial and intramyocardial late gadolinium enhancement (LGE) involving the anterolateral wall is shown as signal hyperintensity (red arrow). (B and C) T2 mapping and T2‐weighted images where residual oedema can be identified in (B) as intramyocardial signal appearing as yellow, which indicates higher T2 signal (black arrow) and in (C) as signal hyperintensity (red arrow). Left coronary artery is visualized.

Discussion

We present a clinical case of a 35‐year‐old patient with no cardiovascular risk factors initially admitted with signs and symptoms compatible with myocardial infarction with ST segment elevation. Coronary angiography revealed the presence of pre‐pulmonic AAOLCA and no coronary obstructions.

Considering the diagnosis of MINOCA, further testing would have been needed for diagnosis as suggested by several diagnostic algorithms of recent guidelines. 5 , 6 None of these algorithms, however, contemplates the presence of CAA, and the finding of anomalous origin of the left coronary artery was suspected to be related to the clinical presentation. The American Association for Thoracic Surgery evidence‐based guidelines suggest surgical repair for patients with AAOCA and symptoms compatible with myocardial ischaemia 2 ; therefore, the patient was referred to our centre. The usual benign prognosis of AAOLCA without inter‐arterial course 1 , 2 suggested a cautious approach despite the recent acute episode. We routinely perform dobutamine stress CMR to search for signs of inducible myocardial ischaemia, as suggested by ESC guidelines on congenital heart disease, 3 and to exclude the presence of ischaemic scar. We are aware that non‐invasive stress imaging has a high positive predictive value but lacks enough sensibility to rule out reduced coronary flow reserve in this setting of patients 2 ; however, no sufficient data are available for stress CMR, which has proven to have higher diagnostic accuracy compared with other non‐invasive functional stress imaging in general population. 7 , 8

In our case, the possibility to exclude reduced coronary flow reserve and detect myocardial tissue alterations by CMR allowed the diagnosis of myocarditis as the most likely cause of the acute presentation. Myocarditis can also explain the high level of hsTnI and C‐reactive protein detected during first hospitalization. Intracoronary ultrasound was performed as suggested by guidelines 1 , 9 to detect potential mechanisms of flow reduction, but no pathological finding was revealed. In our case report, negative intravascular ultrasound and stress CMR prevented the patient from undergoing unnecessary surgical repair.

Conclusion

CA enlist a series of uncommon conditions whose management is not well standardized. After appropriate study of coronary anatomy, accurate risk stratification should go beyond history of symptoms suggestive of ischaemic nature. Our clinical case highlights the importance of CMR both to rule out myocardial ischaemia and to check for tissue abnormalities and other possible causes of chest pain in a patient firstly admitted for suspected acute myocardial infarction. In this regard, CMR plays a pivotal role and should be suggested as part of the diagnostic algorithm of MINOCA despite the evidence of CAA.

Conflict of interest

The authors have nothing to disclose.

Funding

This study was partially supported by Ricerca Corrente funding from the Italian Ministry of Health to IRCCS Policlinico San Donato.

Supporting information

Video S1. Supporting Information

Video S2. Supporting Information

Acknowledgement

Open access funding provided by BIBLIOSAN. [Correction added on 25 November 2022, after first online publication: BIBLIOSAN funding statement has been added.]

Disabato, G. , Camporeale, A. , Lo Rito, M. , Tondi, L. , Zuniga Olaya, K. G. , Frigiola, A. , Agnifili, M. L. , Bedogni, F. , Lombardi, M. , and Pica, S. (2022) Myocardial infarction with non‐obstructive disease and anomalous coronary origin: look for the common in the uncommon. ESC Heart Failure, 9: 3614–3618. 10.1002/ehf2.14075.

References

  • 1. Cheezum MK, Liberthson RR, Shah NR, Villines TC, O'Gara PT, Landzberg MJ, Blankstein R. Anomalous aortic origin of a coronary artery from the inappropriate sinus of Valsalva. J Am Coll Cardiol. 2017; 69: 1592–1608. [DOI] [PubMed] [Google Scholar]
  • 2. Brothers JA, Frommelt MA, Jaquiss RDB, Myerburg RJ, Fraser CD Jr, Tweddell JS. Expert consensus guidelines: Anomalous aortic origin of a coronary artery. J Thorac Cardiovasc Surg. 2017; 153: 1440–1457. [DOI] [PubMed] [Google Scholar]
  • 3. Baumgartner H, de Backer J, Babu‐Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F, Moons P, Mulder BJM, Oechslin E, Roos‐Hesselink JW, Schwerzmann M, Sondergaard L, Zeppenfeld K, ESC Scientific Document Group , Ernst S, Ladouceur M, Aboyans V, Alexander D, Christodorescu R, Corrado D, D'Alto M, de Groot N, Delgado V, di Salvo G, Dos Subira L, Eicken A, Fitzsimons D, Frogoudaki AA, Gatzoulis M, Heymans S, Hörer J, Houyel L, Jondeau G, Katus HA, Landmesser U, Lewis BS, Lyon A, Mueller CE, Mylotte D, Petersen SE, Sonia Petronio A, Roffi M, Rosenhek R, Shlyakhto E, Simpson IA, Sousa‐Uva M, Torp‐Pedersen CT, Touyz RM, van de Bruaene A, Babu‐Narayan SV, Budts W, Chessa M, Diller GP, Iung B, Kluin J, Lang IM, Meijboom F, Moons P, Mulder BJM, Oechslin E, Roos‐Hesselink JW, Schwerzmann M, Sondergaard L, Zeppenfeld K, Hammoudi N, Grigoryan SV, Mair J, Imanov G, Chesnov J, Bondue A, Nabil N, Kaneva A, Brida M, Hadjisavva O, Rubackova‐Popelova J, Nielsen DG, el Sayed MH, Ermel R, Sinisalo J, Thambo JB, Bakhutashvili Z, Walther C, Giannakoulas G, Bálint OH, Lockhart CJ, Murrone ANI:A, Ahmeti A, Lunegova O, Rudzitis A, Saliba Z, Gumbiene L, Wagner K, Caruana M, Bulatovic N, Amri R, Bouma BJ, Srbinovska‐Kostovska E, Estensen ME, Tomkiewicz‐Pajak L, Coman IM, Moiseeva O, Zavatta M, Stojsic‐Milosavljevic A, Simkova I, Prokselj K, Gallego P, Johansson B, Greutmann M, Boughzela E, Sirenko Y, Coats L. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021; 42: 563–645. [DOI] [PubMed] [Google Scholar]
  • 4. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo‐Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, ESC Scientific Document Group , de Boer RA, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes‐Genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, Løchen ML, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen JC, Neubeck L, Noutsias M, Petersen SE, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter DJ, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa‐Uva M, Tocchetti CG, Touyz RM, Tschoepe C, Waltenberger J, Adamo M, Baumbach A, Böhm M, Burri H, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo‐Leiro MG, Farmakis D, Gardner RS, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42: 3599–3726. [DOI] [PubMed] [Google Scholar]
  • 5. Tamis‐Holland JE, Jneid H, Reynolds HR, Agewall S, Brilakis ES, Brown TM, Lerman A, Cushman M, Kumbhani DJ, Arslanian‐Engoren C, Bolger AF, Beltrame JF, American Heart Association Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research . Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: A scientific statement from the American Heart Association. Circulation. 2019; 139: E891–E908. [DOI] [PubMed] [Google Scholar]
  • 6. Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Jüni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM, ESC Scientific Document Group , Kastrati A, Mamas MA, Aboyans V, Angiolillo DJ, Bueno H, Bugiardini R, Byrne RA, Castelletti S, Chieffo A, Cornelissen V, Crea F, Delgado V, Drexel H, Gierlotka M, Halvorsen S, Haugaa KH, Jankowska EA, Katus HA, Kinnaird T, Kluin J, Kunadian V, Landmesser U, Leclercq C, Lettino M, Meinila L, Mylotte D, Ndrepepa G, Omerovic E, Pedretti RFE, Petersen SE, Petronio AS, Pontone G, Popescu BA, Potpara T, Ray KK, Luciano F, Richter DJ, Shlyakhto E, Simpson IA, Sousa‐Uva M, Storey RF, Touyz RM, Valgimigli M, Vranckx P, Yeh RW, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Jüni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST‐segment elevation. Eur Heart J. 2021; 42: 1289–1367. [DOI] [PubMed] [Google Scholar]
  • 7. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck‐Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ, ESC Scientific Document Group . 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41: 407–477. [DOI] [PubMed] [Google Scholar]
  • 8. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S. Cardiovascular magnetic resonance and single‐photon emission computed tomography for diagnosis of coronary heart disease (CE‐MARC): A prospective trial. Lancet. 2012; 379: 453–460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol. 2008; 52: e143–e263. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Video S1. Supporting Information

Video S2. Supporting Information


Articles from ESC Heart Failure are provided here courtesy of Oxford University Press

RESOURCES